Tier 3 · Filer Universe
Inhibikase Therapeutics, Inc.
IKT · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$2.41
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001750149
Liquidity rank
#4179
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $0.00 | 2024-12-31 | 0000950170-25-046096 |
| Annual diluted EPS | -0.49 | 2025-12-31 | 0001193125-26-126371 |
| Quarterly revenue | $0.00 | 2026-03-31 | 0001193125-26-219641 |
| Quarterly diluted EPS | -0.1 | 2026-03-31 | 0001193125-26-219641 |
SEC EDGAR Frames batch generated 2026-08-10T23:34:18.956Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqDHR · Tier 1 peerABT · Tier 1 peerBMY · Tier 1 peerTMO · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames